Literature DB >> 8388298

Pharmacology of GABA rho 1 and GABA alpha/beta receptors expressed in Xenopus oocytes and COS cells.

T Kusama1, C E Spivak, P Whiting, V L Dawson, J C Schaeffer, G R Uhl.   

Abstract

1. The rho 1 protein, which we previously cloned from retina, assembles as a homooligomer that transduces the binding of gamma-aminobutyric acid (GABA) into robust chloride currents. However, its insensitivity to bicuculline, pentobarbitone and benzodiazepines, all potent agents at typical GABAA receptors, suggested that it may react atypically to other GABA agonists and antagonists. 2. cDNAs for the rho 1 and the alpha 5 beta 1 receptors for GABA were expressed as homo- and heterooligomers, respectively, in Xenopus oocytes. The selectivities of the respective receptors for various agonists were investigated using concentration-response experiments in voltage clamped cells. 3. The most potent agonists at the rho 1 receptor were trans-4-aminocrotonic acid (TACA) > GABA > muscimol; at the alpha 5 beta 1 receptor the rank order was muscimol > GABA > 4,5,6,7-tetrahydroisoxazole[4,5-c]pyridine-3-ol (THIP). The most specific agonists were cis-(2-(aminomethyl)-cyclopropyl-carboxylic acid (CAMP) and THIP for the rho 1 and the alpha 5 beta 1 receptors, respectively. 4. Comparing GABA, TACA and cis-aminocrotonic acid (CACA) at rho 1 receptors expressed in COS cells gave results almost indistinguishable from those found at oocytes; the pharmacology of rho 1 seems independent of the expression system. 5. Agonists THIP, piperidine-4-sulphonic acid (P4S), and isoguvacine, whose C-C-C-N chains are constrained by rings into a folded conformation and were potent at the alpha 5 beta 1 receptor, were among the weakest at the rho 1 receptor. However CACA and CAMP, which align better with the extended than the folded conformation, were weakest at the alpha 5 beta 1 receptor but moderately potent at the pl receptor. These findings suggest that the rho l receptor recognizes agonists in the extended conformation, in contrast to GABAA receptors, which are believed to recognize agonists in the partially folded conformation.6. In contrast to the alpha 5 beta 1 receptor, gradations in maximum responses were apparent in the rho l receptor,suggesting various degrees of partial agonism. In particular, imidazole-4-acetic acid (I4AA), whose maximum response was only 3% of GABA's maximum, had an apparent Kd for activating the rho l receptor of 16 microM; but it had an apparent Kd for competitively blocking the receptor of 0.64 microM. This difference suggests that steric constraints in the activated (open channel) receptor are tighter than in the resting receptor.7. Hill coefficients approached 2 at the rho l receptor, but were closer to unity at the alpha 5 beta 1 receptor. Thus,the rho l receptor displayed higher cooperativity.8. Unlike typical GABAA receptors, the rho l receptor was insensitive to the competitive antagonists bicuculline, SR95531, securinine, and (+)-tubocurarine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388298      PMCID: PMC2175610          DOI: 10.1111/j.1476-5381.1993.tb13554.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

Review 1.  GABA synaptic mechanisms: stereochemical and conformational requirements.

Authors:  P Krogsgaard-Larsen
Journal:  Med Res Rev       Date:  1988 Jan-Mar       Impact factor: 12.944

2.  GABA analogues: conformational analysis of effects on [3H]GABA binding to postsynaptic receptors in human cerebellum.

Authors:  S H Nicholson; C J Suckling; L L Iversen
Journal:  J Neurochem       Date:  1979-01       Impact factor: 5.372

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  GABA agonists and antagonists.

Authors:  P R Andrews; G A Johnston
Journal:  Biochem Pharmacol       Date:  1979-09-15       Impact factor: 5.858

5.  The synthesis and activity of cis- and trans-2-(aminomethyl) cyclopropanecarboxylic acid as conformationally restricted analogues of GABA.

Authors:  R D Allan; D R Curtis; P M Headley; G A Johnston; D Lodge; B Twitchin
Journal:  J Neurochem       Date:  1980-03       Impact factor: 5.372

6.  Isothiouronium compounds as gamma-aminobutyric acid agonists.

Authors:  R D Allan; H W Dickenson; B P Hiern; G A Johnston; R Kazlauskas
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

7.  A comparison of gamma-aminobutyric acid and the semi-rigid analogues 4-aminotetrolic acid, 4-aminocrotonic acid and imidazole-4-acetic acid on the isolated superior cervical ganglion of the rat.

Authors:  N G Bowery; G P Jones
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

8.  Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes.

Authors:  C A Drew; G A Johnston; R P Weatherby
Journal:  Neurosci Lett       Date:  1984-12-21       Impact factor: 3.046

9.  3- and 5-isoxazolol zwitterions: an ab initio molecular orbital study relating to GABA agonism and antagonism.

Authors:  T Boulanger; D P Vercauteren; F Durant; J M Andre
Journal:  J Theor Biol       Date:  1987-08-21       Impact factor: 2.691

10.  gamma-Aminobutyric acid A or C receptor? gamma-Aminobutyric acid rho 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive gamma-aminobutyric acid responses in Xenopus oocytes.

Authors:  S Shimada; G Cutting; G R Uhl
Journal:  Mol Pharmacol       Date:  1992-04       Impact factor: 4.436

View more
  28 in total

1.  Evidence that GABA rho subunits contribute to functional ionotropic GABA receptors in mouse cerebellar Purkinje cells.

Authors:  Victoria L Harvey; Ian C Duguid; Cornelius Krasel; Gary J Stephens
Journal:  J Physiol       Date:  2006-08-31       Impact factor: 5.182

Review 2.  Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships.

Authors:  Renê Oliveira Beleboni; Ruither Oliveira Gomes Carolino; Andrea Baldocchi Pizzo; Lissandra Castellan-Baldan; Joaquim Coutinho-Netto; Wagner Ferreira dos Santos; Norberto Cysne Coimbra
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

3.  Allosteric modulation of retinal GABA receptors by ascorbic acid.

Authors:  Cecilia I Calero; Evan Vickers; Gustavo Moraga Cid; Luis G Aguayo; Henrique von Gersdorff; Daniel J Calvo
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

4.  Immunocytochemical localization of the GABAc receptor rho subunits in the mammalian retina.

Authors:  R Enz; J H Brandstätter; H Wässle; J Bormann
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

Review 5.  GABAC receptors in the vertebrate retina.

Authors:  P D Lukasiewicz
Journal:  Mol Neurobiol       Date:  1996-06       Impact factor: 5.590

Review 6.  GABA-ρ receptors: distinctive functions and molecular pharmacology.

Authors:  Moawiah M Naffaa; Sandy Hung; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

7.  Pharmacological characterization of the excitatory 'Cys-loop' GABA receptor family in Caenorhabditis elegans.

Authors:  Georgina C B Nicholl; Ali K Jawad; Robert Weymouth; Haoming Zhang; Asim A Beg
Journal:  Br J Pharmacol       Date:  2017-03-10       Impact factor: 8.739

8.  Cationic modulation of rho 1-type gamma-aminobutyrate receptors expressed in Xenopus oocytes.

Authors:  D J Calvo; A E Vazquez; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 9.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

Review 10.  GABA effects during neuronal differentiation of stem cells.

Authors:  Patricia Salazar; Marco A Velasco-Velázquez; Iván Velasco
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.